SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001654954-17-010672
Filing Date
2017-11-14
Accepted
2017-11-14 17:23:44
Documents
8

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT TO FORM S-3 acer_posam.htm POS AM 455157
2 CONSENT OF WOLF & COMPANY, P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM acer_ex23-2.htm EX-23.2 4474
3 CONSENT OF MALONEBAILEY, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM acer_ex23-3.htm EX-23.3 4476
4 IMAGE acer_posam000.jpg GRAPHIC 5902
5 IMAGE acer_posam001.jpg GRAPHIC 12926
6 IMAGE acer_posam002.jpg GRAPHIC 9563
7 IMAGE acer_posam003.jpg GRAPHIC 13015
8 IMAGE acer_posam004.jpg GRAPHIC 5902
  Complete submission text file 0001654954-17-010672.txt   531263
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-208314 | Film No.: 171203087
SIC: 2834 Pharmaceutical Preparations